Company Filing History:
Years Active: 2020
Title: Innovations by Norm Greenberg in Antibody Research
Introduction
Norm Greenberg, an accomplished inventor based in San Carlos, California, has made significant contributions to the field of antibody research. With his expertise and innovative mindset, he has developed methods that are transformative for interrogating antibody repertoires.
Latest Patents
One of his notable patents is titled "Use of nanoexpression to interrogate antibody repertoires." This patent discloses methods and compositions for utilizing nanoexpression techniques to explore antigen specificity within various antibody repertoires. The invention also reveals an antibody display system composition, which includes recombinant nucleic acid sequences that encode specific variable region sequences of heavy and light chain antibodies, thereby enhancing the efficiency of antibody analysis.
Career Highlights
Currently, Norm Greenberg is affiliated with Atreca, Inc., a company recognized for its innovative approaches in the biotechnology sector. His work at Atreca involves leveraging cutting-edge technology to advance antibody therapies and diagnostics.
Collaborations
Throughout his career, Norm has collaborated with other notable professionals in the industry, including Jeff DeFalco and Daniel Eric Emerling. These partnerships have fostered a creative and dynamic research environment, propelling advancements in antibody technology.
Conclusion
With his pioneering contributions to antibody research and a strong patent portfolio, Norm Greenberg exemplifies the vital role of inventors in the biotechnology field. His work not only enhances our understanding of the immune response but also pushes the boundaries of innovation in medical research.